[1] OLVEIRA G,GONZÁLEZ-MOLERO I.An update on probiotics,prebiotics and symbiotics in clinical nutrition[J].Endocrinologia y Nutricion,2016,63(9):482-494.
[2] CHANG C J,LIN T L,TSAI Y L,et al.Next generation probiotics in disease amelioration[J].Journal of Food and Drug Analysis,2019,27(3):615-622.
[3] BUI T P N,DE VOS W M.Next-generation therapeutic bacteria for treatment of obesity,diabetes,and other endocrine diseases[J].Best Practice&Research.Clinical Endocrinology&Metabolism,2021,35(3):101504.
[4] SATOKARI R.Modulation of gut microbiota for health by current and next-generation probiotics[J].Nutrients,2019,11(8):1921.
[5] FENG Q Q,CHEN W D,WANG Y D.Gut microbiota:an integral moderator in health and disease[J].Frontiers in Microbiology,2018,9:151.
[6] SINGH T P,NATRAJ B H.Next-generation probiotics:a promising approach towards designing personalized medicine[J].Critical Reviews in Microbiology,2021,47(4):479-498.
[7] O'TOOLE P W,MARCHESI J R,HILL C.Next-generation probiotics:the spectrum from probiotics to live biotherapeutics[J].Nature Microbiology,2017,2:17057.
[8] LIN T L,SHU C C,LAI W F,et al.Investiture of next generation probiotics on amelioration of diseases-strains do matter[J].Medicine in Microecology,2019,1/2:100002.
[9] DERRIEN M,VAUGHAN E E,PLUGGE C M,et al.Akkermansia muciniphila gen.nov.,sp.nov.,a human intestinal mucin-degrading bacterium[J].International Journal of Systematic and Evolutionary Microbiology,2004,54(Pt.5):1469-1476.
[10] REUNANEN J,KAINULAINEN V,HUUSKONEN L,et al.Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer[J].Applied and Environmental Microbiology,2015,81(11):3655-3662.
[11] 闫丹丽,武俊瑞,史海粟,等.下一代益生菌——卵形拟杆菌研究进展[J].乳业科学与技术,2020,43(1):50-54.YAN D L,WU J R,SHI H S,et al.Recent progress in a next generation probiotic,Bacteroides ovatus[J].Journal of Dairy Science and Technology,2020,43(1):50-54.(in Chinese)
[12] ULSEMER P,HENDERSON G,TOUTOUNIAN K,et al.Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6[J].Cancer Immunology,Immunotherapy,2013,62(5):875-887.
[13] ROUND J L,MAZMANIAN S K.Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota[J].Proceedings of the National Academy of Sciences of the United States of America,2010,107(27):12204-12209.
[14] SEARS C L,ISLAM S,SAHA A,et al.Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea[J].Clinical Infectious Diseases,2008,47(6):797-803.
[15] ULSEMER P,TOUTOUNIAN K,KRESSEL G,et al.Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults[J].Beneficial Microbes,2016,7(4):485-500.
[16] ULSEMER P,TOUTOUNIAN K,KRESSEL G,et al.Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults[J].Beneficial Microbes,2012,3(2):99-111.
[17] ULSEMER P,TOUTOUNIAN K,SCHMIDT J,et al.Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate[J].Applied and Environmental Microbiology,2012,78(2):528-535.
[18] ULSEMER P,TOUTOUNIAN K,SCHMIDT J,et al.Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964[J].Regulatory Toxicology and Pharmacology,2012,62(2):336-346.
[19] BRODMANN T,ENDO A,GUEIMONDE M,et al.Safety of novel microbes for human consumption:practical examples of assessment in the European Union[J].Frontiers in Microbiology,2017,8:1725.
[20] GÉRARD P,LEPERCQ P,LECLERC M,et al.Bacteroides sp.strain D8,the first cholesterol-reducing bacterium isolated from human feces[J].Applied and Environmental Microbiology,2007,73(18):5742-5749.
[21] PEDERSEN H K,GUDMUNDSDOTTIR V,NIELSEN H B,et al.Human gut microbes impact host serum metabolome and insulin sensitivity[J].Nature,2016,535(7612):376-381.
[22] CANI P D,DE VOS W M.Next-generation beneficial microbes:the case of Akkermansia muciniphila[J].Frontiers in Microbiology,2017,8:1765.
[23] EVERARD A,BELZER C,GEURTS L,et al.Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity[J].Proceedings of the National Academy of Sciences of the United States of America,2013,110(22):9066-9071.
[24] PLOVIER H,EVERARD A,DRUART C,et al.A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice[J].Nature Medicine,2017,23(1):107-113.
[25] CANI P D,GEURTS L,MATAMOROS S,et al.Glucose metabolism:focus on gut microbiota,the endocannabinoid system and beyond[J].Diabetes&Metabolism,2014,40(4):246-257.
[26] WANG Y M,MA R N,LIU F,et al.Modulation of gut microbiota:a novel paradigm of enhancing the efficacy of programmed death-1 and programmed death ligand-1 blockade therapy[J].Frontiers in Immunology,2018,9:374.
[27] CHEN D F,JIN D C,HUANG S M,et al.Clostridium butyricum,a butyrate-producing probiotic,inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota[J].Cancer Letters,2020,469:456-467.
[28] DUNCAN S H,HOLD G L,HARMSEN H J M,et al.Growth requirements and fermentation products of Fusobacterium prausnitzii,and a proposal to reclassify it as Faecalibacterium prausnitzii gen.nov.,comb.nov[J].International Journal of Systematic and Evolutionary Microbiology,2002,52(Pt 6):2141-2146.
[29] WRZOSEK L,MIQUEL S,NOORDINE M L,et al.Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent[J].BMC Biology,2013,11:61.
[30] PARK Y J,KUEN D S,CHUNG Y.Future prospects of immune checkpoint blockade in cancer:from response prediction to overcoming resistance[J].Experimental&Molecular Medicine,2018,50(8):1-13.
[31] LI C,CHEN X,KOU L,et al.Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor[J].Experimental and Therapeutic Medicine,2010,1(1):129-135.
[32] FU G F,LI X,HOU Y Y,et al.Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer[J].Cancer Gene Therapy,2005,12(2):133-140.
[33] CHANG C J,LIN C S,LU C C,et al.Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota[J].Nature Communications,2015,6:7489.
[34] GOPALAKRISHNAN V,SPENCER C N,NEZI L,et al.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J].Science,2018,359(6371):97-103.
[35] DASGUPTA S,ERTURK-HASDEMIR D,OCHOA-REPARAZ J,et al.Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms[J].Cell Host&Microbe,2014,15(4):413-423.
[36] LUKIW W J.Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease[J].Frontiers in Microbiology,2016,7:1544.
[37] UDAYAPPAN S,MANNERAS-HOLM L,CHAPLIN-SCOTT A,et al.Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice[J].NPJ Biofilms and Microbiomes,2016,2:16009.
[38] ENGELS C,RUSCHEWEYH H J,BEERENWINKEL N,et al.The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation[J].Frontiers in Microbiology,2016,7:713.
[39] GAUTIER T,DAVID-LE GALL S,SWEIDAN A,et al.Next-generation probiotics and their metabolites in COVID-19[J].Microorganisms,2021,9(5):941.
[40] ALMEIDA D,MACHADO D,ANDRADE J C,et al.Evolving trends in next-generation probiotics:a 5W1H perspective[J].Critical Reviews in Food Science and Nutrition,2020,60(11):1783-1796.
[41] CANI P D,VAN HUL M.Novel opportunities for next-generation probiotics targeting metabolic syndrome[J].Current Opinion in Biotechnology,2015,32:21-27.
[42] ZHANG W D,ZHU B,XU J H,et al.Bacteroides fragilis protects against antibiotic-associated diarrhea in rats by modulating intestinal defenses[J].Frontiers in Immunology,2018,9:1040.
[43] ALAMEDDINE J,GODEFROY E,PAPARGYRIS L,et al.Faecalibacterium prausnitzii skews human DC to prime IL10-producing T cells through TLR2/6/JNK signaling and IL-10,IL-27,CD39,and IDO-1 induction[J].Frontiers in Immunology,2019,10:143.
[44] 赵雪娇,李文茜.抗菌肽的生物学功能和作用机制[J].畜牧兽医科技信息,2015(8):15-16.ZHAO X J,LI W Q.Biological function and mechanism of antimicrobial peptides[J].Chinese Journal of Animal Husbandry and Veterinary Medicine,2015(8):15-16.(in Chinese)
[45] HANSEN K B,ROSENKILDE M M,KNOP F K,et al.2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans[J].The Journal of Clinical Endocrinology and Metabolism,2011,96(9):E1409-E1417.
[46] 陈鹏.细菌素在动物饲料中的替抗应用[J].饲料研究,2021,44(18):150-153.CHEN P.Antibiotic replacement application of bacteriocins in animal feed[J].Feed Research,2021,44(18):150-153.(in Chinese)
[47] QUINTANA-HAYASHI M P,PADRA M,PADRA J T,et al.Mucus-pathogen interactions in the gastrointestinal tract of farmed animals[J].Microorganisms,2018,6(2):55.
[48] 周洁,朱俊萍,诸欣平.益生菌对肠道疾病的作用机制及应用进展[J].中国新药杂志,2015,24(13):1484-1487.ZHOU J,ZHU J P,ZHU X P.Action mechanisms and application of probiotics in intestinal diseases[J].Chinese Journal of New Drugs,2015,24(13):1484-1487.(in Chinese)
[49] DAI C,ZHAO D H,JIANG M.VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways[J].International Journal of Molecular Medicine,2012,29(2):202-208.
[50] BELZER C,DE VOS W M.Microbes inside-from diversity to function:the case of Akkermansia[J].The ISME Journal,2012,6(8):1449-1458.
[51] DEPOMMIER C,VAN HUL M,EVERARD A,et al.Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice[J].Gut Microbes,2020,11(5):1231-1245.
[52] OTTMAN N,REUNANEN J,MEIJERINK M,et al.Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function[J].PLoS One,2017,12(3):e0173004.
[53] ZHAI Q X,FENG S S,ARJAN N,et al.A next generation probiotic,Akkermansia muciniphila[J].Critical Reviews in Food Science and Nutrition,2019,59(19):3227-3236.
[54] OUWERKERK J P,VAN DER ARK K C H,DAVIDS M,et al.Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer[J].Applied and Environmental Microbiology,2016,82(23):6983-6993.
[55] HUANG J Y,LEE S M,MAZMANIAN S K.The human commensal Bacteroides fragilis binds intestinal mucin[J].Anaerobe,2011,17(4):137-141.
[56] DAVIS-RICHARDSON A G,ARDISSONE A N,DIAS R,et al.Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes[J].Frontiers in Microbiology,2014,5:678.
[57] YOSHIDA N,EMOTO T,YAMASHITA T,et al.Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis[J].Circulation,2018,138(22):2486-2498.
[58] TAN H Z,ZHAI Q X,CHEN W.Investigations of Bacteroides spp.towards next-generation probiotics[J].Food Research International,2019,116:637-644.
[59] 陈映宇,毛联智,刘华缓,等.肠道产丁酸菌防治炎症性肠病的机制研究进展[J].世界华人消化杂志,2019,27(14):907-912.CHEN Y Y,MAO L Z,LIU H H,et al.Mechanism of gut butyric acid producing bacteria for prevention and treatment of inflammatory bowel disease[J].World Chinese Journal of Digestology,2019,27(14):907-912.(in Chinese)
[60] CAO G T,TAO F,HU Y H,et al.Positive effects of a Clostridium butyricum-based compound probiotic on growth performance,immune responses,intestinal morphology,hypothalamic neurotransmitters,and colonic microbiota in weaned piglets[J].Food&Function,2019,10(5):2926-2934.
[61] 何家俊,吴汉葵,杨昕涧,等.丁酸梭菌对犊牛生长性能和血清生化、抗氧化、免疫指标及粪便微生物数量的影响[J].动物营养学报,2021,33(9):5076-5085.HE J J,WU H K,YANG X J,et al.Effects of Clostridium butyricum on growth performance,serum biochemical,antioxidant,immune indexes and fecal microorganism number of calves[J].Chinese Journal of Animal Nutrition,2021,33(9):5076-5085.(in Chinese)
[62] ARAKI Y,ANDOH A,TAKIZAWA J,et al.Clostridium butyricum,a probiotic derivative,suppresses dextran sulfate sodium-induced experimental colitis in rats[J].International Journal of Molecular Medicine,2004,13(4):577-580.
[63] HILL C,GUARNER F,REID G,et al.Expert consensus document.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J].Nature Reviews.Gastroenterology&Hepatology,2014,11(8):506-514.
[64] YASUEDA A,MIZUSHIMA T,NEZU R,et al.The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis[J].Surgery Today,2016,46(8):939-949.
[65] AGOSTONI C,CANANI R B,FAIRWEATHER-TAIT S,et al.Scientific opinion on the safety of'heat-treated milk products fermented with Bacteroides xylanisolvens DSM 23964'as a novel food[J].EFSA Journal,2015,13(1):3956.
京公网安备 11010802041926号